Capricor Therapeutics, Inc. (CAPR) stock
CAPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$10.24−0.98 (-8.73%)
Close on Nov 12, 2026Market cap $595.34MP/E –Yield –
Capricor Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Capricor Therapeutics's operating margin for the twelve months ending Dec 31, 2024 was -191.1%. For fiscal 2024 it was -191.1%, against -95.6% the year before. The highest annual figure on record is -95.6% in fiscal 2023.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -191.1% | −95.5 |
| FY2023 | Dec 31, 2023 | -95.6% | +1068.3 |
| FY2022 | Dec 31, 2022 | -1163.9% | +7385.9 |
| FY2021 | Dec 31, 2021 | -8549.9% | −4137.3 |
| FY2020 | Dec 31, 2020 | -4412.6% | −3643.0 |
| FY2019 | Dec 31, 2019 | -769.5% | +147.5 |
| FY2018 | Dec 31, 2018 | -917.0% | −434.6 |
| FY2017 | Dec 31, 2017 | -482.4% | −57.8 |
| FY2016 | Dec 31, 2016 | -424.6% | −196.0 |
| FY2015 | Dec 31, 2015 | -228.6% | −102.8 |
| FY2014 | Dec 31, 2014 | -125.7% | +1246.0 |
| FY2013 | Dec 31, 2013 | -1371.7% | −297.5 |
| FY2012 | Dec 31, 2012 | -1074.2% | −712.5 |
| FY2011 | Dec 31, 2011 | -361.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -69.1% | −58.5 |
| Q3 FY2024 | Sep 30, 2024 | -575.2% | −464.3 |
| Q2 FY2024 | Jun 30, 2024 | -291.9% | −94.1 |
| Q1 FY2024 | Mar 31, 2024 | -209.2% | +64.8 |
| Q4 FY2023 | Dec 31, 2023 | -10.6% | +829.7 |
| Q3 FY2023 | Sep 30, 2023 | -111.0% | +296.0 |
| Q2 FY2023 | Jun 30, 2023 | -197.8% | +2293.0 |
| Q1 FY2023 | Mar 31, 2023 | -274.0% | +12370.7 |
| Q4 FY2022 | Dec 31, 2022 | -840.3% | +6388.7 |
| Q3 FY2022 | Sep 30, 2022 | -407.0% | +22804.0 |
| Q2 FY2021 | Jun 30, 2021 | -2490.7% | +4504.0 |
| Q1 FY2021 | Mar 31, 2021 | -12644.8% | −11509.8 |
| Q4 FY2020 | Dec 31, 2020 | -7229.0% | −6561.1 |
| Q3 FY2020 | Sep 30, 2020 | -23211.0% | −22065.4 |
| Q2 FY2020 | Jun 30, 2020 | -6994.7% | −6491.3 |
| Q1 FY2020 | Mar 31, 2020 | -1134.9% | −25.6 |
| Q4 FY2019 | Dec 31, 2019 | -667.9% | −157.8 |
| Q3 FY2019 | Sep 30, 2019 | -1145.7% | +757.2 |
| Q2 FY2019 | Jun 30, 2019 | -503.4% | +527.2 |
| Q1 FY2019 | Mar 31, 2019 | -1109.4% | −188.0 |
| Q4 FY2018 | Dec 31, 2018 | -510.1% | +179.3 |
| Q3 FY2018 | Sep 30, 2018 | -1902.8% | −1060.8 |
| Q2 FY2018 | Jun 30, 2018 | -1030.5% | −691.5 |
| Q1 FY2018 | Mar 31, 2018 | -921.4% | −516.6 |
| Q4 FY2017 | Dec 31, 2017 | -689.5% | −368.2 |
| Q3 FY2017 | Sep 30, 2017 | -842.0% | – |
| Q2 FY2017 | Jun 30, 2017 | -339.1% | – |
| Q1 FY2017 | Mar 31, 2017 | -404.8% | – |
| Q4 FY2016 | Dec 31, 2016 | -321.2% | – |
See a number that looks wrong?